|Systematic (IUPAC) name|
| (what is this?)
R-4066 is a drug which is an analogue of the opioid analgesic methadone, where the metabolically labile dimethylamino group has been replaced by a piperidinospiro group. Developed by Janssen Pharmaceutica, it is around 212x more potent than methadone as an analgesic in animal tests, with an effective oral dosage of 0.07 mg/kg, but is slightly shorter acting, with a duration of action of around 3 hours. If the ketone function is reduced and acetylated, the (R) isomer of the resultant compound is equipotent and has an analgesic duration of 20.5 hours compared to 8 hours for methadone.
R-4066 has never been used in humans, but would be expected to produce effects similar to those of other potent opioid agonists, including strong analgesia, sedation, euphoria, constipation, itching and respiratory depression which could be harmful or fatal.
- US patent 3125580, Paul A. J. Janssen., "N-(3,3-DIPHENYL-3-ALKANOYL)PROPYLSPIRO(TETRALIN-1,4'-PIPERIDINES) AND RELATED COMPOUNDS", published 1961-10-10, issued 1964-03-17
- Frincke JM, Henderson GL, Janssen PAJ, Van der Eycken CAM. Synthesis and analgesic activity of some long-acting piperidinospiro derivatives of methadone. Journal of Medicinal Chemistry. 1978 May;21(5):474-6. PMID 660594
- J. Med. Chem. 1978, 21 (5) pages 474-476 DOI: 10.1021/jm00203a014
|This analgesic-related article is a stub. You can help Wikipedia by expanding it.|